Logo slider

OUR COMPANIES

GRUPO BIOTOSCANA
Read More

GRUPO BIOTOSCANA

Grupo Biotoscana (GBT) is an advanced biopharmaceutical company in Latin America. With operations in 10 countries throughout the region, GBT maintains pan-regional presence with a focus on specialty pharmaceuticals, world-class licensed products and proprietary branded generics. GBT markets leading brands in the fields of high-complexity genetic disorders, rare disease, oncology, hematology, infectious disease, HIV and specialty treatments. Backed by Advent International and Essex Woodlands, GBT was later acquired by Knight Therapeutics Inc. (TSX: GUD)
FORESSE MEDICAL
Read More

FORESSE MEDICAL

ForeSee Medical is the healthcare industry’s leading software platform designed to increase the profitability of Medicare Advantage risk contracts. Using proprietary clinical algorithms, including natural language processing (NLP) and machine learning, ForeSee Medical perfects HCC risk adjustment scores, empowering providers to maximize health outcomes.
CPG DIAGNOSTICS
Read More

CPG DIAGNOSTICS

CPG Diagnostics is the developer of OvaPrint, a demonstrated liquid biopsy for early-stage epithelial ovarian cancer. Using Next Generation Sequencing, OvaPrint serves as a pre-operative diagnostic measuring cell-free DNA methylation. OvaPrint distinguishes between benign and malignant lesions with near perfect sensitivity and specificity, avoiding false positive or negatives and providing true confidence in early stage ovarian cancer diagnostics. OvaPrint is now under evaluation as an early detection screening test.
STATIONHEAD
Read More

STATIONHEAD

Stationhead is a fast-growing mobile social media network that allows everyone – music artists and fans alike - to become the DJ of their own global radio station, all from a smart phone. Stationhead is post-market, post-revenue and is partnered with the major streaming services including Apple and Spotify. Stationhead’s IP revolutionizes the calculation of music licensing fees through its proprietary de-coupling technology.
UBIETY
Read More

UBIETY

Ubiety is a next-generation security solution designed to increase community safety by identifying perpetrators in the process of committing a crime. Using a combined evolutionary sensor array and data analytics platform, Ubiety enables the last mile of identification by capturing data signals from a wide range of electronic devices . Ubiety users include individual home owners as well as municipal police departments in major cities throughout the country.
ZENCREDIT
Read More

ZENCREDIT

ZenCredit is a venture lending and syndication platform specializing in high-yield alternative finance. ZenCredit Ventures invests in post-market small business funding companies with a proven track record of success using scale, diversification and operational controls to mitigate risk. ZenCredit Systems is the first accelerator index of small business funding in the United States.
STERIFARMA
Read More

STERIFARMA

Sterifarma is Brazil’s fastest growing supplier of advanced solutions for hospitals, offering customized systems in medical materials applied directly to surgical and post-surgical procedures. Sterifarma is exclusively partnered with several global brands including Hemacalear and Physicool.
PERISHIP
Read More

PERISHIP

PeriShip provides high-touch, end-to-end logistics management from a sophisticated IT platform with proprietary databases, package and flight-tracking software, weather, and flight status monitoring systems, as well as dynamic dashboards with real-time visibility into shipment transit and last-mile events. In April 2022, Periship was acquired by VerifyMe Inc. (NASDAQ: VRME).
AQUA MEDICAL
Read More

AQUA MEDICAL

Aqua Medical is an early stage medical device company that specializes in vapor ablation technology to treat a variety of gastrointestinal diseases including esophageal and pancreatic cancers. Aqua Medical’s disruptive pipeline endoscopic therapies serve as a platform to provide a faster, more effective treatment for Barrett’s esophagus and the only effective, non-surgical treatment for pancreatic cysts.
BRILLI LIGHT BULB
Read More

BRILLI LIGHT BULB

The Brilli Light Bulb Company offers a high-quality and energy efficient home lighting solution for consumers. Brilli is based on Tesla Technology™, a patented technology which produces a unique color spectrum that LED and other bulbs cannot. Brilli is on shelf at over 1,400 retail doors in the United States and is available online at Amazon, Wayfair, Staples etc...
APTIVITI
Read More

APTIVITI

Aptiviti is a next generation, B2B research and due diligence platform serving Fortune 500 technology enterprises seeking more precise insight into the needs of CTOs, CIOs and other leaders driving their respective markets. Using non-traditional data science and automation, Aptiviti's market research and data visualization platform compresses the due diligence while increasing accuracy in market trends.
ZIPPZ
Read More

ZIPPZ

ZIPPZ is a subscription – based service that combines the best proven practices of pharmaceutical companies and physicians to help consumers find the right cannabis products to meet their wellness needs. This includes an online patient evaluation process, online recommendation engine and a scientifically created line of cannaceutical products for conditions such as pain, sleep, and anxiety.
NEUBASE THERAPEUTICS
Read More

NEUBASE THERAPEUTICS

NeuBase Therapeutics, Inc. is a developer of RNA gene silencing technology, combining the advantages of synthetic approaches with the precision of antisense technologies. Through the application of its modular PATrOL™ platform, NeuBase has demonstrated the potential to improve upon current gene silencing treatments and will use its platform to address repeat expansion disorders, with an initial focus on Huntington’s Disease, Myotonic Dystrophy, as well as other dominant genetic disorders. In 2019, NeuBase merged with Ohr Pharmaceutical, to be traded under NBSE (NASDAQ).
MEDECELL
Read More

MEDECELL

Medecell do Brasil is the premier developer of innovative electro-stimulation products (TENS) for pain relief and athletic performance. Medecell operates in several countries throughout the western hemisphere including Brazil, Argentina, Chile and the United States. Medecell is the creator of Tanyx, the world’s only single-use TENS application in the form factor of a band-aid. Medecell has partnered with Bayer for distribution of the Tanyx platform in North America.
SPEXIS
Read More

SPEXIS

Spexis AG is a leading specialty biopharmaceutical company with a strategic focus on chronic respiratory diseases, oncology and antimicrobial resistance. Spexis’ macrocyclic peptide technology platform has evolved into a renewable discovery engine for a wide range of therapeutic targets that have been leveraged by third party biotech firms. In December 2021, two companies – Polyphor and EnBiotix – teamed up to join forces and formed Spexis which is now publicly traded under the ticker symbol (Ticker.SW) on the SIX Swiss Exchange.

INVESTOR PORTAL

DELTA GLOBAL IS POWERED BY CARTA ® ADMINISTRATIVE SERVICES

CONTACT US